Merck halts Gardasil shipments to China, withdraws $11B sales target as demand nosedives
The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country. | The recent decline of Merck & Co.
Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...
During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...
Before the Senate's confirmation vote on President Donald Trump’s pick for secretary of the Department of Health and Human ...
The drug company’s outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback